Principal Financial Group Inc Alkermes Plc. Transaction History
Principal Financial Group Inc
- $176 Billion
- Q2 2025
A detailed history of Principal Financial Group Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Principal Financial Group Inc holds 914,795 shares of ALKS stock, worth $28.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
914,795
Previous 928,865
1.51%
Holding current value
$28.3 Million
Previous $30.7 Million
14.67%
% of portfolio
0.01%
Previous 0.02%
Shares
32 transactions
Others Institutions Holding ALKS
# of Institutions
393Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$901 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$573 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$311 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$254 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$198 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.08B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...